TAMPA, Fla. – Dr. Jonathan Zager, a surgical oncologist and senior member in the Cutaneous Oncology and Sarcoma departments at Moffitt Cancer Center, has a new title to add to his business card. The clinician and researcher is a Councilor-at-Large on the Society of Surgical Oncology’s Executive Council, where he will provide input on the strategic direction of the society and its programs.
The society’s membership elected Zager in March, and he represents the interest of members under the age of 45. He also serves as an Ex Officio member and the Executive Council liaison to the Colorectal Disease Site Workgroup and the Hepato-Pancreato-Biliary Disease Work Group.
“I am honored and humbled that the council voted for me to be in this role,” Zager said. “This is a society in which I believe in and is a way for surgical oncologists to poll resources and research to advance the science and treatment of cancer.”
While Zager has been elected to his new position, he continues his membership on the society’s Regional Cancer Therapies Committee.
Zager is a professor of Surgery at the University of South Florida, Morsani School of Medicine. His research and clinical interests include the regional therapy treatment of cutaneous melanoma and non-melanoma skin cancers, as well as soft tissue sarcomas. Zager has extensively studied and performed isolated limb infusions for in transit or recurrent extremity melanoma and unresectable extremity sarcomas and percutaneous hepatic perfusions for unresectable melanoma to the liver.
The Society of Surgical Oncology (SSO) is the premier organization for surgeons and health care providers dedicated to advancing and promoting the science and treatment of cancer. The Society’s focus on all solid-tumor disease sites is reflected in its Annual Cancer Symposium, monthly scientific journal (Annals of Surgical Oncology), educational initiatives and committee structure. The Society’s mission is to improve multidisciplinary patient care by advancing the science, education and practice of cancer surgery worldwide.
About Moffitt Cancer Center Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 47 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, clinical trials, prevention and cancer control. Moffitt is the No. 6 cancer hospital in the nation and has been listed in U.S. News & World Report as one of the “Best Hospitals” for cancer care since 1999. Moffitt devotes more than 2.5 million square feet to research and patient care. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 5,200 team members, Moffitt has an economic impact in the state of $2.1 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, Twitter and YouTube.